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Introduction: Cluster of differentiation 64 (CD64) is expressed on neutrophils during bacterial 
infections and sepsis. The aim of our study was to assess the CD64 expression in patients admitted 
to the emergency department (ED) with a triage diagnosis of acute respiratory failure (ARF) 
and/or dyspnea and to verify a relationship between its value and the presence of infection.
Methods: We assessed neutrophil CD64 expression in peripheral blood of patients admitted to 
the ED with a diagnosis of ARF and/or dyspnea from September 2012 to April 2013. We mea-
sured CD64 index by flow cytometry (Leuko64™ kit) and classified patients as infected within 
12 hours from admission, without an infection within 12 hours but infected within 72 hours 
from admission, and not infected. The primary outcome was differentiating CD64 values of 
patients with a diagnosis of infection within 12 hours and 72 hours from admission, from those 
of patients without a diagnosis of infection. The secondary outcome was verifying a relationship 
between CD64 values and patients’ characteristics, Sequential Organ Failure Assessment score, 
and intensive care unit admission.
Results: Of 212 patients included in the study, 40.1% were classified as infected within 12 hours 
from admission, 20.3% were without an infection 12 hours after admission but were infected within 
72 hours, and 39.6% were not infected. The median CD64 index was higher in patients with an 
infection on admission (CD64 index: 3.58) than in those not considered infected (CD64 index: 
1.37), P,0.0001. Among patients not infected at admission, the CD64 index was higher in those 
with an infection detected during the following hours of observation (CD64 index: 2.75) than in 
patients without a diagnosis of infection (CD64 index: 1.28), P,0.0001. A CD64 index .3.65 
showed a sensitivity of 94.6%, a specificity of 86.8%, and an area under the receiver-operating 
characteristic curve of 0.952 for prediction of intensive care unit admission.
Conclusion: CD64 index could represent a useful diagnostic tool for differential diagnosis 
of ARF in the ED.
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Introduction
Acute respiratory failure (ARF) is a major cause of admission in an emergency 
department (ED), and the identification of the underlying cause may be challenging.1,2 
A timely administration of antibiotics in patients with infection has been advocated 
as a measure to reduce mortality3–5 and as a quality of care indicator.6,7 Cluster of dif-
ferentiation 64 (CD64), is the high-affinity immunoglobulin fragment crystallizable 
(Fc) receptor (FcγRI). It is expressed on cells of myeloid lineage, playing a key role in 
phagocytosis, clearance of immune complexes, antigen presentation, and cytokine 
release.8,9 On resting neutrophils its expression is negligible, but it gradually increases 
under stimulation by inflammatory cytokines such as granulocyte colony-stimulating 
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factor (G-CSF) and interferon (IFN)-γ.9 Previous studies 
indicated that quantitative neutrophil CD64 expression is a 
sensitive and specific tool for diagnosis of sepsis in adults,10–14 
neonates, and children,15 and others have studied quantitative 
neutrophil CD64 as an indicator of bacterial infection and 
sepsis in an ED setting.16,17 The aim of our study was to assess 
the CD64 expression in ED patients admitted with a triage 
diagnosis of ARF and/or dyspnea and to verify a relationship 
between its value and the presence of infection. Moreover, we 
sought to determine if a single dose of CD64 on admission 
could predict the diagnosis of infection established within 
72 hours from admission in those patients not considered 
infected during the first 12 hours. Finally we wanted to verify 
a relationship between CD64 among patients with a diagnosis 
of infection and admission to the intensive care unit (ICU) 
within 72 hours.
Methods
We obtained the approval from the ethics committee 
 (Comitato Bioetico Azienda Ospedaliera Universitaria Poli-
clinico P Giaccone) for this study. We conducted a prospective 
study from September 2012 to April 2013 in the Emergency 
Department (ED) of an urban, tertiary care, teaching hospital 
(Paolo Giaccone, Palermo, Italy) with approximately 30,000 
ED patient visits per year. We enrolled patients aged 18 years 
or older who were admitted with a nursing first-contact diag-
nosis (triage process) of ARF and/or dyspnea. We excluded 
patients with neutropenia (absolute neutrophil count ,1500 
cells/µL) or myeloproliferative or lymphoproliferative disor-
ders, or treated with chemotherapy.
The physicians treated all enrolled patients according to 
their own clinical judgment. Blood samples for neutrophil 
CD64 quantification were collected together with those 
required for first laboratory tests performed before any 
therapeutic intervention. Laboratory technicians who dosed 
CD64 expression were blinded to the patients’ clinical data. 
After patients’ discharge or death, the researchers reviewed 
the clinical records of each enrolled patient and collected data 
on a standardized form. They recorded age, sex, comorbidi-
ties (acute coronary syndromes [ACS], chronic obstructive 
pulmonary disease [COPD], chronic heart failure [CHF]), 
and antibiotic treatment, and they calculated the Sequential 
Organ Failure Assessment (SOFA) score with available data 
(worst findings) within 12 hours from ED admission. The 
researchers classified patients as infected or not infected 
within 12 hours and 72 hours from ED admission. For this 
purpose, they registered the final diagnosis of physicians 
in charge and analyzed clinical signs, laboratory data, 
and radiological findings relative to the first 12 hours from 
ED admission and daily up to 72 hours.
During the retrospective analysis, in order to limit elements 
of subjectivity, they followed the criteria for diagnosing infec-
tion in an acute care-setting provided by the US Centers for 
Disease Control and Prevention/National Health Care Safety 
network.18 When a discrepancy was encountered between the 
diagnosis made by physicians who treated the patient and 
researchers’ classification or among researchers’ judgment, a 
final decision was made by review of clinical data, discussion 
and consensus. The same process was adopted in order to solve 
any doubtful case. The researchers were blind to CD64 value 
results during the whole clinical data collection, and CD64 
values became available only after the complete clinical record 
review and classification of each enrolled patient.
Primary outcomes were differentiating CD64 values of 
patients with a diagnosis of infection within 12 hours and 
72 hours from admission from those of patients without a 
diagnosis of infection. The secondary outcome was verifying 
a relationship between CD64 values and patients’ charac-
teristics, SOFA score, and ICU admission. We adhered to 
the Strengthening the Reporting of Observational Studies 
in Epidemiology (STROBE) guidelines for conducting and 
reporting this observational study.19
Neutrophil CD64 index quantification
CD64 levels were studied through a flow cytometric 
analysis; results were expressed as the standardized CD64 
index and collected into a database for later analysis. 
 Ethylenediaminetetraacetic acid samples were processed 
as soon as available or refrigerated (2°C–8°C) according 
to logistic organization. Neutrophil CD64 expression was 
measured using the Leuko64™ kit (Trillium Diagnostics, 
LLC, Brewer, ME, USA) and CD64 index was calculated 
using QuantiCALC™ software (Trillium  Diagnostics, LLC). 
The CD64 index is obtained from the ratio of the mean fluo-
rescent intensity of the cell population to that of calibrated, 
fluorescent beads used for standardization and included in 
the kit.20 Flow cytometry was performed by the Coulter® 
Epic XL™ flow cytometer (Beckman Coulter, Inc., Miami, 
FL, USA). According to manufacturer’s instructions,20 an 
internal negative control (lymphocyte CD64 index ,1) and 
an internal positive control (monocyte CD64 index .3) were 
used to validate each sample.
Statistical analysis
Variable distribution was analyzed by D’Agostino–Pearson’s 
test. Variables without a normal distribution were expressed 
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Eligible patients
(n=221)
Enrolled patients
(n=212)
Clinical signs of 
infection on admission
(n=85)
No clinical signs of 
infection on admission
(n=127)
Clinical signs of 
infection within
72 hours
(n=43)
Infection ruled out
(n=84)
Excluded patients
(n=9)
•  Hematologic disease (one patient
    with multiple myeloma, one patient
    with chronic lymphocytic
       leukemia) (n=2)
•  Neutropenia (n=3)
•  Chemotherapy (n=4)
Figure 1 Study flow chart. 
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as median and interquartile ranges (IQR; 25th–75th) and 
comparisons were performed through Mann–Whitney test. 
Spearman’s rank correlation coefficient (rho) was used to 
evaluate the correlation between variables. Subgroup analysis 
was  performed using the Kruskall–Wallis test for continuous 
variables. A frequency table was constructed and the chi-square 
test was adopted for comparison of more than two propor-
tions.  Fisher’s exact test was adopted for comparison of two 
proportions. Receiver-operating characteristic (ROC) curves 
were created for the CD64 index and its sensitivity, specificity, 
positive predictive value, and negative predictive value, along 
with their 95% confidence intervals (CI), were calculated. The 
best CD64 cut-off values for infection within 72 hours and 
ICU admission were calculated. The area under the ROC curve 
(AUC) for both variables were also determined. 
A value of P,0.05 was considered statistically 
significant. Statistical analysis was performed using MedCalc 
for Windows, version 9.5.0.0 (MedCalc statistical software; 
Mariakerke, Belgium).
Results
The flowchart of eligible and enrolled patients is shown in 
Figure 1. The characteristics of the 212 study patients are 
summarized in Table 1.
Of 212 patients included in the study, 85 (40.1%) had 
signs of infection within 12 hours from ED admission. Of 
these, 12 had an extrapulmonary source of infection (six 
urinary tract infections, four abdominal infections, and two 
soft tissue infections). In 127 patients (59.9%), a diagnosis 
of infection was not made within 12 hours from admission. 
However, in 43 patients (20.3%) an infection was observed 
within 72 hours from admission. Among these, eight patients 
had an extrapulmonary source of infection (five urinary 
tract infections and three abdominal infections). Treatment 
included antibiotics in seven patients (16.3%) not consid-
ered infected on admission but meeting criteria for infec-
tion within 72 hours. Antibiotics were used in nine patients 
(10.7%) who did not meet criteria for infection during the 
period of observation. These last two groups were not differ-
ent according to the proportion of antibiotic use (P=0.40). 
Associated diagnoses in patients without clinical signs of 
infection are described in Table 2.
The median CD64 index value was 3.58 (IQR 3.00–4.55) 
in patients with a diagnosis of infection within 12 hours from 
ED admission and 1.37 (IQR 1.19–2.35) in patients without 
a diagnosis of infection within 12 hours (P,0.0001; effect 
size, r=0.69) (Figure 2). A cutoff of 2.79 for the CD64 index 
showed 82.3% sensitivity, 88.2%  specificity, and an AUC of 
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Table 1 Clinical characteristics of enrolled patients relative to time from admission in the emergency department
Patient  
characteristics
Signs of infection  
within 12 hours  
(n=85) (A)
Signs of infection  
within 72 hours  
(n=43) (B)
No signs of infection  
within 72 hours  
(n=84) (C)
P-value All patients 
(n=212)
Age (years, range) 65.0 (59.0–71.0) 66.0 (60.0–72.7) 62.0 (51.0–71.0) 0.122 65.1
Sex, n (%) M=43 (50.6) 
F=42 (49.4)
M=61 (47.6) 
F=67 (52.4)
M=47 (55.9) 
F=37 (44.1)
0.322 M=108 (50.9) 
F=104 (49.1)
SOFA 3 (1–5) 1 (1–2) 1 (1–2) ,0.0001* 2
Comorbidities (%) 
  History of ACS 
History of COPD 
History of CHF
 
18 (21. 2) 
61 (71.8) 
8 (9.41)
 
5 (11.6) 
31 (72.1) 
4 (9.30)
 
39 (46.4) 
13 (15.5) 
24 (28.6)
 
,0.001 
,0.0001 
0.0013
 
62 (29.2) 
105 (49.5) 
36 (17.0)
WBC count (×106 cells/L) 17,400 (14,300–23,500) 13,200 (12,300–14,900) 11,670 (9,115–16,555) ,0.001* 14,200
Neutrophils (×106 cells/L) 14,200 (11,600–19,050) 10,700 (10,100–12,175) 9,360 (7,190–13,455) ,0.001* 11,600
Notes: Chi-square test was used for comparison of proportions. Kruskall–Wallis test was used for comparison of continuous variables. *A different from B and C.
Abbreviations: A, patients infected within 12 hours from admission; B, patients infected within 72 hours from admission; C, patients not infected; M, male; F, female; SOFA, 
sequential organ failure assessment; ACS, acute coronary syndrome; COPD, chronic obstructive pulmonary disease; CHF, chronic heart failure; WBC, white blood cell.
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0.933 for prediction of infection within 12 hours from ED 
admission (Figure 3). Among patients without a diagnosis 
of infection on admission, the median CD64 index of 2.75 
(IQR 2.34–3.00) was significantly higher in those who met 
criteria for infection between 12 hours and 72 hours from 
admission than in those with a ruled out diagnosis of infec-
tion (CD64 index: 1.28, IQR 1.12–1.37, P,0.0001, r=0.81) 
(Figure 4). A CD64 index .1.73 showed 99% sensitivity, 
96.4% specificity, a positive predictive value of 93.5% (95% 
CI =82.1%–98.6%), a negative predictive value of 100.0% 
(95% CI =95.5%–100.0%) and an AUC of 98.9 for prediction 
of infection during the 72 hours of postadmission observa-
tion in patients not considered infected within 12 hours from 
admission. The CD64 index showed a weak correlation with 
age (r=0.242, P=0.0004) and a moderate  correlation21 with 
white blood cell count (r=0.639, P,0.0001), neutrophil 
count (r=0.637, P,0.0001), and SOFA score (r=0.534, 
P,0.0001) (Figure 5). Patients  admitted to the ICU within 
72 hours from admission showed a significantly higher CD64 
index (CD64 index: 4.55, IQR 4.11–5.07) than those not 
admitted to the ICU within the observation interval (CD64 
index: 2.92, IQR 2.52–3.38, P,0.0001). The ROC curve of 
CD64 index for prediction of ICU admission within 72 hours 
from the first ED observation is shown in Figure 6. A CD64 
index $3.65 was predictive of ICU admission within 72 
hours, with a sensitivity of 94.6%, a specificity of 86.8%, 
and an AUC of 0.952.
Discussion
In recent years, several biomarkers were evaluated as diagnos-
tic tools and for prognostic purposes in patients with infec-
tion and sepsis in ED and ICU settings. In an ED, an ideal 
biomarker would improve the initial diagnostic assessment of 
patients presenting with an infection and thus lead to timely 
institution of antibiotic therapy, an appropriate duration of 
Table 2 Associated diagnoses in patients without clinical signs 
of infection within 72 hours from admission in the emergency 
department
Associated diagnosis 
with respiratory failure
No clinical signs of infection 
within 72 hours from 
admission (n=84, 39.6%)
Pulmonary edema n=53, 63.1%
Pulmonary embolism n=12, 14.3%
COPD n=6, 7.14%
Severe asthma n=4, 4.76%
Drug overdose n=3, 3.57%
Pneumothorax n=2, 2.38%
Trauma n=2, 2.38%
Inhalation n=2, 2.38%
Abbreviation: COPD, chronic obstructive pulmonary disease.
0
Patients without a
 diagnosis of infection
  within 12 hours
 from admission
C
D
64
 in
d
ex
Patients with a
diagnosis of infection
within 12 hours
from admission
1
2
3
4
5
6
7
Figure 2 Boxplot distribution of the CD64 index in noninfected and infected 
patients within 12 hours from admission in the emergency department. 
Abbreviation: CD64, cluster of differentiation 64.
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therapy, and the identification of patients with the most severe 
conditions requiring intensive care.12,13,15,17,22 Neutrophil CD64 
expression was studied in adults,10–14 infants, and children15 as 
an early marker of bacterial infection and sepsis. Its negligible 
expression in healthy subjects, its prompt upregulation under 
inflammatory cytokine stimulation,16 and its biochemical sta-
bility at room temperature for more than 30 hours23 represent 
favorable properties as a marker in an ED setting.
Moreover, neutrophil CD64 expression seems to be useful 
in distinguishing systemic infections from other inflamma-
tory conditions.11,24 A meta-analysis of published studies 
involving patients of all age groups12 revealed a pooled 
sensitivity of 79%, a specificity of 91%, and an AUC of 
0.94 for neutrophil CD64 as a marker of bacterial infection. 
However, a subgroup analysis revealed a higher performance 
in the adult population (a mean sensitivity of 90%, a mean 
specificity of 95%, and an AUC of 0.97). Our study sug-
gests a similar high diagnostic accuracy of the CD64 index 
when adopted as a marker of infection in patients admitted 
to the ED with a diagnosis of ARF (a sensitivity of 82.3%, a 
specificity of 88.2%, and an AUC of 0.933 for prediction of 
infection within 12 hours from ED admission).
It is difficult to compare our results to those of previous 
studies, as in most of them neutrophil CD64 expression was 
studied with regard of its ability to predict a culture-proven 
infection. As a result, optimal diagnostic cutoffs were vari-
able and may also have depended on time of presentation, 
severity of clinical condition, pathogen characteristics, and 
antibiotic therapy before admission.25 Gámez-Díaz et al,17 in 
a study including septic patients recently admitted to the ED, 
reported a sensitivity of 65.8% and a specificity of 64.6% 
for CD64 as predictive marker of infection defined by an 
experts’ consensus diagnosis. In the population studied, 22% 
of patients were affected by community-acquired pneumonia 
and the median CD64 was 2.1 MESF (molecules of equiva-
lent soluble fluorochrome) units in this group. Interestingly, 
a higher CD64 index was measured among patients who met 
criteria for infection during the 72-hour period of observa-
tion but who were not considered infected during the initial 
evaluation. Compared with white blood cell count, neutrophil 
count, and SOFA score, the CD64 index was revealed to be 
a good predictor of infection and could be a useful tool in 
order to differentiate patients with an infection detected dur-
ing subsequent hours of observation from those without an 
infection. Although Davis et al16 showed a weak correlation 
between CD64 and neutrophil count, we agree with their 
proposed explanation, namely the different specificity for 
detection of an acute inflammatory response or a different 
kinetic during the dynamic process of inflammatory response 
to infection.
Our decision to limit the period of observation to 72 hours 
from ED admission to follow-up the clinical evolution (a new 
diagnosis of infection or ICU admission) arose from the 
need to avoid confounding factors such as hospital-acquired 
infection and ventilator-associated pneumonia (in those 
patients admitted to ICU after endotracheal intubation).26,27 
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Figure 3 Receiver-operating characteristic curve of CD64 index for prediction of 
infection within 12 hours from admission in the emergency department.
Abbreviations: CD64, cluster of differentiation 64; +PV, positive predictive 
value; -PV, negative predictive value; AUC, area under the receiver-operating 
characteristic curve; CI, confidence interval.
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Figure 4 Boxplot distribution of the CD64 index in patients without a diagnosis 
of infection within 72 hours from admission in the emergency department and in 
patients without an infection at admission who met criteria for infection within the 
72-hour observation period. 
Abbreviation: CD64, cluster of differentiation 64.
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History of COPD was present in 72.1% of patients with signs 
of infection observed within 72 hours from admission. One of 
the treatments of exacerbations of COPD is corticosteroids.28 
However, in our study, blood specimens for CD64 analysis 
were obtained before any therapeutic intervention. Of note, 
it has previously reported that corticosteroids may not have 
an influence on CD64 expression by neutrophils.24 Patients 
with severe sepsis or septic shock exhibit a higher level of 
neutrophil CD64 expression compared to those with a less-
severe infection.29
Moreover, a prognostic value for the CD64 index has been 
recently detected.30 We chose ICU admission as secondary 
outcome since it is a more practical indicator of the severity 
of illness. In our study, CD64 index showed a high sensitivity 
(94.6%) and specificity (86.8%) for ICU admission within 72 
hours from ED admission. However, ICU admission decision, 
through guided by an institutional protocol, comes from a 
complete assessment of clinical condition (ie, comorbidities 
and their severities), and this result should be considered 
in light of this multifactorial scenario. To date, our study 
represents the first attempt to evaluate the performance of 
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CD64 index not solely as predictor of positive cultures in a 
population with bacterial infection and/or sepsis, but also 
for an operational use in detection of patients with infection 
in a daily ED setting.
Emergency physicians deal with elderly patients with 
various comorbidities2 and are asked for a timely diagnosis 
and institution of therapy.3 Our selected patients, therefore, 
were representative of the general population of patients 
admitted to our ED. The adoption of Centers for Disease 
Control and Prevention/National Health Care Safety Network 
criteria for diagnosing infections and the discussion of all 
doubtful cases by the team in order to meet a final classifica-
tion of patients by consensus represents our attempt to limit 
possible elements of subjectivity. Although these criteria 
have been formulated for diagnosis of health care-associated 
infections, they consist of clinical, laboratory, and radiologi-
cal findings that commonly characterize patients presenting 
to the ED with infections.
A limitation of the study is the unique determination of 
the CD64 index due to economic reasons. In our opinion, 
this could not be enough to represent the complex dynamic 
process of inflammation and its evolution after therapy 
institution. Nevertheless, a punctual neutrophil CD64 
quantification was revealed to be a useful tool, especially 
for diagnosis of infection in those patients without clini-
cal signs on admission. Another limitation is the lack of 
comparison of the CD64 index with a validated marker of 
infection. Procalcitonin is a marker of bacterial infection31 
and it has been studied as a tool in algorithms for diag-
nosis and prognosis of community-acquired pneumonia25 
and as a guide for antibiotic therapy in the emergency 
setting.32 However, because this study represents the first 
attempt to evaluate the diagnostic performance of the 
CD64 index in the general population admitted to the ED, 
further studies are needed to confirm our results, evalu-
ate the cost-effectiveness of this marker, and eventually 
compare its diagnostic performance with other markers 
of infection.
Conclusion
According to our study results, the CD64 index seems able 
to differentiate patients with ARF and/or dyspnea and with a 
clinically evident infection from those not considered infected 
within 12 hours and 72 hours from ED admission. Moreover, 
it seems to identify those patients requiring intensive care 
within 72 hours. Neutrophil CD64 index could represent a 
useful diagnostic tool for the differential diagnosis of these 
patients in the ED.
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